Fundraising Fox

Atia Vision

Campbell, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

HC
Henry ChenNamed on SEC filing
CA
Claudio ArgentoNamed on SEC filing
MM
Mariam MaghribiNamed on SEC filing
AS
Amr SalahiehNamed on SEC filing
CG
Casey GordonNamed on SEC filing

Investors · 2

Rising TidePacifica
ShangBay Capital LLCPalo Alto

Reported raises · per SEC filings

Form D private placements

$51M disclosed across 5 rounds · 2018–2022

▶$28.6MraisedAug 2022 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bihua ChenDirector
  • Claudio ArgentoDirector
  • Mariam MaghribiExecutive Officer, Director
  • Casey GordonDirector
  • Amr SalahiehDirector
Offering amount
$28.6M
Amount sold
$28.6M
Minimum investment
$15K
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedNov 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bihua ChenDirector
  • Casey GordonDirector
  • Amr SalahiehDirector
  • Mariam MaghribiExecutive Officer, Director
  • Claudio ArgentoDirector
Offering amount
$6.5M
Amount sold
$5.4M
Minimum investment
$31K
First sale
Nov 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.6MraisedMay 2019 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mariam MaghribiExecutive Officer, Director
  • Amr SalahiehDirector
  • Bihua ChenDirector
  • Casey GordonDirector
  • Claudio ArgentoDirector
Offering amount
$20M
Amount sold
$11.6M
Minimum investment
$25K
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedNov 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Casey GordonDirector
  • Mariam MaghribiExecutive Officer, Director
  • Claudio ArgentoDirector
  • Henry ChenDirector
  • Amr SalahiehDirector
Offering amount
$3.3M
Amount sold
$3.3M
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedApr 2018 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Henry ChenDirector
  • Claudio ArgentoDirector
  • Mariam MaghribiExecutive Officer, Director
  • Amr SalahiehDirector
  • Casey GordonDirector
Offering amount
$2M
Amount sold
$2M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Atia Vision, a Shifamed Portfolio Company, to Close on $42m Series E Financing - Atia Visionatiavision.com · Aug 2022Atia Vision Closes Second Tranche of $20M in Series D Financing - Atia Visionatiavision.com · May 2020Atia Vision closes $20m Series D - MassDevicemassdevice.com · May 2020Atia Vision Closes $10M In Series C Financing - FinSMEsfinsmes.com · Dec 2018

Frequently asked questions

Who are Atia Vision's investors?
Atia Vision's investors include Rising Tide, ShangBay Capital LLC.
How much funding has Atia Vision raised?
Atia Vision has disclosed $51M raised across 5 rounds.
Where is Atia Vision headquartered?
Atia Vision is headquartered in Campbell, US.